Domperidone for lactation: What health care providers really should know

Research output: Contribution to journalLetterpeer-review

7 Citations (Scopus)


In a recent commentary, Sewell et al lament the limited quality evidence for the effectiveness of domperidone for lactation enhancement in contrast to the apparent considerable information on domperidone's cardiac risk among lactating women.1 Such considerable information is either extrapolated from observational studies among nonlactating adults or restricted to a small number of adverse event reports submitted to the U.S. Food and Drug Administration, with the authors later highlighting the lack of reliable information from previous pharmacoepidemiologic studies to adequately inform the risk of harm in breastfeeding women.
Original languageEnglish
Pages (from-to)913
Number of pages1
JournalObstetrics and Gynecology
Issue number4
Publication statusPublished - Oct 2017
Externally publishedYes


  • Domperidone
  • lactation
  • cardiac risk factors
  • pharmacoepidemiology
  • Breastfeeding


Dive into the research topics of 'Domperidone for lactation: What health care providers really should know'. Together they form a unique fingerprint.

Cite this